Quoin Pharmaceuticals Ownership | Who Owns Quoin Pharmaceuticals?
Quoin Pharmaceuticals Ownership Summary
Quoin Pharmaceuticals is owned by 64.70% institutional investors, 8.77% insiders, and 26.53% retail investors. Citadel advisors is the largest institutional shareholder, holding 0% of QNRX shares. abrdn World Healthcare is the top mutual fund, with 2.01% of its assets in Quoin Pharmaceuticals shares.
QNRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Quoin Pharmaceuticals | 64.70% | 8.77% | 26.53% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Citadel advisors | - | - | - |
| Centiva capital, lp | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Citadel advisors | - | - | - |
| Centiva capital, lp | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Citadel advisors | - | - | -32.52K |
| Centiva capital, lp | - | - | -60.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Centiva capital, lp | - | - | -60.00K |
| Citadel advisors | - | - | -32.52K |
Sold Out
| Holder | Change |
|---|---|
| Citadel advisors | -32.52K |
| Centiva capital, lp | -60.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 19 | -5.00% | 1,299,393 | 9.68% | 64 | 1.77% | 10 | -16.67% | 3 | -25.00% |
| Mar 31, 2026 | 20 | - | 1,184,710 | - | 60 | - | 20 | - | - | - |
| Mar 31, 2023 | 1 | - | 2,000 | -50.00% | - | 384.12% | - | -100.00% | 1 | - |
| Dec 31, 2022 | 1 | - | 4,000 | - | - | - | 1 | - | - | - |
| Jun 30, 2022 | 8 | 60.00% | 169,917 | 17.54% | - | 492.62% | 5 | 25.00% | 1 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| abrdn World Healthcare | 40.40K | 2.01% | - |
| abrdn Life Sciences Investors | 34.60K | 1.72% | - |
| Abante Quant Value FI | 5.34K | 0.36% | - |
| Fidelity Nasdaq Composite Index | 95.00 | 0.00% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Carter Denise P. | Chief Operating Officer | Buy | $62.49K |
| Aug 31, 2026 | Carter Denise P. | Chief Operating Officer | Buy | $99.99K |
| Aug 31, 2026 | Myers Michael | Chief Executive Officer | Buy | $62.49K |
| Aug 31, 2026 | Myers Michael | Chief Executive Officer | Buy | $99.99K |
| Aug 31, 2026 | Lawlor Sally Bridget | Chief Financial Officer | Buy | $49.99K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 8 | - |
| 2026 Q1 | - | - |
| 2025 Q4 | 5 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
QNRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools